» Authors » Susannah Ellsworth

Susannah Ellsworth

Explore the profile of Susannah Ellsworth including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 439
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu Y, Zhao C, Ji R, Chen W, Shen Q, Chiang C, et al.
J Natl Cancer Cent . 2024 Jul; 2(3):171-182. PMID: 39036452
Hepatocellular carcinoma (HCC) is a common malignancy with high mortality rates. While surgery can be curative in early-stage disease, 80% of patients cannot undergo surgical resection. Stereotactic body radiotherapy (SBRT),...
2.
Das R, McGrath K, Seiser N, Smith K, Uttam S, Brand R, et al.
Clin Gastroenterol Hepatol . 2020 Dec; 20(4):886-897. PMID: 33278573
Background & Aims: The assessment of therapeutic response after neoadjuvant treatment and pancreatectomy for pancreatic ductal adenocarcinoma (PDAC) has been an ongoing challenge. Several limitations have been encountered when employing...
3.
Mohan R, Liu A, Brown P, Mahajan A, Dinh J, Chung C, et al.
Neuro Oncol . 2020 Aug; 23(2):284-294. PMID: 32750703
Background: We investigated differences in radiation-induced grade 3+ lymphopenia (G3+L), defined as an absolute lymphocyte count (ALC) nadir of <500 cells/µL, after proton therapy (PT) or X-ray (photon) therapy (XRT)...
4.
Huang C, Shiue K, Bartlett G, Agrawal N, Arbab M, Maxim P, et al.
Med Dosim . 2020 Apr; 45(3):293-297. PMID: 32249105
Purpose: We demonstrate proof of principle that normal tissue doses can be greatly reduced in lung stereotactic body radiation therapy (SBRT) for mobile tumors, if the delivered dose is split...
5.
Jin J, Mereniuk T, Yalamanchali A, Wang W, Machtay M, Kong F, et al.
Radiother Oncol . 2019 Dec; 144:105-113. PMID: 31794944
Introduction: Associations between radiation-induced lymphopenia (RIL) and survival have been extensively reported. However, the immune system is not considered as an organ-at-risk (OAR) in radiotherapy. This study aimed to develop...
6.
Fogel E, Shahda S, Sandrasegaran K, DeWitt J, Easler J, Agarwal D, et al.
Am J Gastroenterol . 2017 Feb; 112(4):537-554. PMID: 28139655
In this article, we review our multidisciplinary approach for patients with pancreatic cancer. Specifically, we review the epidemiology, diagnosis and staging, biliary drainage techniques, selection of patients for surgery, chemotherapy,...
7.
Fan K, Wild A, Halappa V, Kumar R, Ellsworth S, Ziegler M, et al.
Contemp Clin Trials . 2016 Aug; 50:143-9. PMID: 27520932
Objective: Yttrium-90 (Y-90) radioembolization is an emerging treatment option for unresectable neuroendocrine liver metastases (NELM). However, the data regarding this treatment are currently limited. This study evaluates the efficacy and...
8.
Miljkovic M, Grossman S, Ye X, Ellsworth S, Terezakis S
Cancer Invest . 2016 Jan; 34(1):32-8. PMID: 26745229
Adults with cancer commonly develop severe lymphopenia two months following chemoradiation therapy, which is an independent predictor of survival. In this retrospective study of 53 children with central nervous system...
9.
Ellsworth S, Ye X, Grossman S
Am J Clin Oncol . 2015 Oct; 40(3):219-222. PMID: 26491903
Purpose: Patients with glioblastoma (GBM) frequently deteriorate clinically and radiographically after chemoradiation and may require repeat surgical intervention. We attempted to correlate pathologic findings with preoperative clinical characteristics and survival...
10.
Grossman S, Ellsworth S, Campian J, Wild A, Herman J, Laheru D, et al.
J Natl Compr Canc Netw . 2015 Oct; 13(10):1225-31. PMID: 26483062
Background: The immune system plays an important role in cancer surveillance and therapy. Chemoradiation can cause severe treatment-related lymphopenia (TRL) (<500 cells/mm3) that is associated with reduced survival. Materials And...